{"id":"bf-200-ala-1","safety":{"commonSideEffects":[{"rate":"20-30%","effect":"Local skin reactions (e.g., erythema, edema, crusting)"},{"rate":"10-20%","effect":"Pain during illumination"}]},"_chembl":{"chemblId":"CHEMBL3781418","moleculeType":"Protein","molecularWeight":"3638.56"},"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"The active ingredient, aminolevulinic acid (ALA), is converted into protoporphyrin IX (PpIX) within cells. Upon illumination with specific wavelengths of light, PpIX becomes excited and produces reactive oxygen species, leading to photodynamic damage and cell death, particularly in rapidly dividing cells such as those found in certain skin conditions and cancers.","oneSentence":"BF-200 ALA 1% is a topical photosensitizer that, when activated by light, generates reactive oxygen species to induce cell death in targeted tissues.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:23:23.842Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Actinic keratosis"},{"name":"Superficial basal cell carcinoma"}]},"trialDetails":[{"nctId":"NCT06876038","phase":"PHASE2","title":"Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions","status":"NOT_YET_RECRUITING","sponsor":"University of Massachusetts, Boston","startDate":"2026-09","conditions":"Oral Cancer, Oral Cavity Cancer, Oral Leukoplakia","enrollment":65},{"nctId":"NCT07225621","phase":"PHASE2","title":"Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma","status":"RECRUITING","sponsor":"Alpheus Medical, Inc.","startDate":"2026-01-28","conditions":"Glioblastoma, GBM","enrollment":103},{"nctId":"NCT07241585","phase":"NA","title":"Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)","status":"NOT_YET_RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2026-05-01","conditions":"Nonmelanoma Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma","enrollment":54},{"nctId":"NCT06417281","phase":"PHASE3","title":"Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid（5-ALA）","status":"COMPLETED","sponsor":"Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.","startDate":"2024-06-19","conditions":"5-aminolevulinic Acid, Malignant Glioma of Brain","enrollment":86},{"nctId":"NCT07144345","phase":"PHASE3","title":"Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2025-11-19","conditions":"Actinic Keratosis","enrollment":160},{"nctId":"NCT06665724","phase":"PHASE1","title":"Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)","status":"COMPLETED","sponsor":"Universität Münster","startDate":"2025-01-27","conditions":"Anaplastic Astrocytoma (AA), Anaplastic Oligodendroglioma (AO), Glioblastoma (GBM)","enrollment":16},{"nctId":"NCT07038278","phase":"EARLY_PHASE1","title":"5-AminoLevulinic Acid Aided Resection Margins in Sarcoma","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-04-01","conditions":"Soft Tissue Sarcoma (STS)","enrollment":20},{"nctId":"NCT07076472","phase":"EARLY_PHASE1","title":"Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-08-14","conditions":"Progressive Glioblastoma, Recurrent Glioblastoma","enrollment":8},{"nctId":"NCT06307548","phase":"PHASE1, PHASE2","title":"Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer","status":"SUSPENDED","sponsor":"Roswell Park Cancer Institute","startDate":"2024-07-30","conditions":"Locally Advanced Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Stage III Colorectal Cancer","enrollment":21},{"nctId":"NCT06623201","phase":"PHASE1","title":"Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas","status":"RECRUITING","sponsor":"Nathalie Zeitouni","startDate":"2024-10-07","conditions":"Basal Cell Carcinoma (BCC)","enrollment":20},{"nctId":"NCT03573401","phase":"PHASE3","title":"Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biofrontera Inc.","startDate":"2018-09-25","conditions":"Superficial Basal Cell Carcinoma","enrollment":187},{"nctId":"NCT05080764","phase":"PHASE2","title":"Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biofrontera Inc.","startDate":"2021-12-10","conditions":"Acne Vulgaris","enrollment":126},{"nctId":"NCT05020912","phase":"PHASE2","title":"Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2021-12-13","conditions":"Basal Cell Carcinoma","enrollment":28},{"nctId":"NCT07164053","phase":"","title":"Evaluation of Image Quality and Safety of the MyVeo Surgical Visualization Headset During Standard Neurosurgical and Reconstructive Procedures Using Compatible Microscopes.","status":"NOT_YET_RECRUITING","sponsor":"Leica Microsystems (Schweiz) AG","startDate":"2025-12-25","conditions":"High-Grade Glioma (WHO III-IV), Cerebral Vascular Conditions Requiring Surgical Intervention, Conditions Requiring Plastic and Reconstructive Surgery","enrollment":32},{"nctId":"NCT04381806","phase":"PHASE1","title":"Phase I Study in Advanced Malignancies With 5-ALA","status":"SUSPENDED","sponsor":"Fox Chase Cancer Center","startDate":"2020-07-30","conditions":"Solid Tumor","enrollment":130},{"nctId":"NCT05736406","phase":"PHASE1, PHASE2","title":"A Dose-escalation Clinical Study of Intraoperative Photodynamic Therapy of Glioblastoma","status":"RECRUITING","sponsor":"Hemerion Therapeutics","startDate":"2024-02-20","conditions":"Primary Glioblastoma","enrollment":12},{"nctId":"NCT06455189","phase":"PHASE1","title":"Magnetic Resonance Fingerprinting Guided Extended Resection in Glioblastomas","status":"NOT_YET_RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2025-12","conditions":"Glioblastoma, Brain Tumor","enrollment":114},{"nctId":"NCT07027670","phase":"PHASE2","title":"Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-02-01","conditions":"Cardiac Surgical Procedures, Coronary Artery Bypass, Aortic Valve Disease","enrollment":48},{"nctId":"NCT05362409","phase":"PHASE1","title":"Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma","status":"COMPLETED","sponsor":"Alpheus Medical, Inc.","startDate":"2022-06-29","conditions":"High Grade Glioma","enrollment":22},{"nctId":"NCT06160492","phase":"PHASE3","title":"Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)","status":"RECRUITING","sponsor":"Lee's Pharmaceutical Limited","startDate":"2025-04-14","conditions":"5-aminolevulinic Acid, Fluorescence-guided Resection","enrollment":144},{"nctId":"NCT03066843","phase":"NA","title":"Photodynamic Therapy Incubation Times for Actinic Keratosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwestern University","startDate":"2017-03-01","conditions":"Actinic Keratoses","enrollment":60},{"nctId":"NCT06039709","phase":"PHASE1","title":"Sonodynamic Therapy in Patients With Recurrent GBM","status":"RECRUITING","sponsor":"Shayan Moosa, MD","startDate":"2024-01-31","conditions":"Recurrent Glioblastoma, Glioblastoma Multiforme, GBM","enrollment":11},{"nctId":"NCT05060237","phase":"PHASE1","title":"Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2021-12-01","conditions":"Actinic Keratosis, Keratosis, Actinic, Keratosis","enrollment":112},{"nctId":"NCT05123534","phase":"PHASE2","title":"A Phase 2 Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Patients with DIPG","status":"SUSPENDED","sponsor":"SonALAsense, Inc.","startDate":"2022-08-12","conditions":"Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma","enrollment":15},{"nctId":"NCT05370508","phase":"PHASE1, PHASE2","title":"A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM","status":"TERMINATED","sponsor":"SonALAsense, Inc.","startDate":"2023-02-06","conditions":"Recurrent GBM","enrollment":8},{"nctId":"NCT04305470","phase":"PHASE3","title":"Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma","status":"COMPLETED","sponsor":"NX Development Corp","startDate":"2020-10-28","conditions":"Meningioma","enrollment":108},{"nctId":"NCT06418113","phase":"PHASE1","title":"Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma","status":"RECRUITING","sponsor":"Hospital San Carlos, Madrid","startDate":"2024-03-21","conditions":"Glioblastoma, Glioblastoma Multiforme, Glioblastoma, IDH-wildtype","enrollment":12},{"nctId":"NCT04164849","phase":"PHASE1, PHASE2","title":"Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid","status":"COMPLETED","sponsor":"University Hospital, Akershus","startDate":"2019-11-22","conditions":"Crohn Disease","enrollment":7},{"nctId":"NCT01128218","phase":"PHASE1, PHASE2","title":"A Study of the Specificity and Sensitivity of 5- Aminolevulinic Acid (ALA) Fluorescence in Malignant Brain Tumors","status":"COMPLETED","sponsor":"Southern Illinois University","startDate":"2011-03","conditions":"Brain Neoplasms","enrollment":33},{"nctId":"NCT01502280","phase":"PHASE3","title":"Fluorescence-guided Surgery for Low- and High-grade Gliomas","status":"COMPLETED","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2010-11","conditions":"Glioma","enrollment":127},{"nctId":"NCT02124733","phase":"PHASE3","title":"Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2014-04","conditions":"Actinic Keratosis","enrollment":23},{"nctId":"NCT01966120","phase":"PHASE3","title":"Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2013-10","conditions":"Actinic Keratosis","enrollment":87},{"nctId":"NCT05929456","phase":"PHASE1","title":"Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)","status":"UNKNOWN","sponsor":"University Medical Center Groningen","startDate":"2023-05-05","conditions":"Glioblastoma, High-grade Glioma","enrollment":21},{"nctId":"NCT05850377","phase":"","title":"5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas","status":"NOT_YET_RECRUITING","sponsor":"Sociedad de Lucha Contra el Cáncer del Ecuador","startDate":"2023-06-01","conditions":"High Grade Glioma, Glioma, Glioma, Malignant","enrollment":90},{"nctId":"NCT02698293","phase":"PHASE1","title":"PDT Plus Vitamin D3 for Anal Dysplasia","status":"WITHDRAWN","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2019-12-01","conditions":"Anal Dysplasia, Carcinoma in Situ","enrollment":""},{"nctId":"NCT02144077","phase":"PHASE3","title":"Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2014-01-28","conditions":"Basal Cell Carcinoma (BCC)","enrollment":281},{"nctId":"NCT05547516","phase":"NA","title":"Blue Laser -5ala Photodynamic Therapy (PDT) in High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients","status":"UNKNOWN","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2022-09-13","conditions":"Non-muscle-invasive Bladder Cancer","enrollment":140},{"nctId":"NCT05234346","phase":"NA","title":"ALACOVID Study for Vaccinated Subjects","status":"COMPLETED","sponsor":"Vedic Lifesciences Pvt. Ltd.","startDate":"2022-03-15","conditions":"COVID-19 Respiratory Infection","enrollment":200},{"nctId":"NCT03322293","phase":"PHASE1","title":"Daylight Photodynamic Therapy for Actinic Keratosis","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2017-12-01","conditions":"Actinic Keratoses","enrollment":24},{"nctId":"NCT05228483","phase":"NA","title":"Carbon Dioxide（CO2）Fractional Laser Plus Photodynamic Therapy in Female Patients With Vulvar Lichen Sclerosus","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2021-11-23","conditions":"Vulva Lichen Sclerosus","enrollment":134},{"nctId":"NCT04319159","phase":"PHASE1","title":"Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2020-03-05","conditions":"Actinic Keratoses","enrollment":48},{"nctId":"NCT04854876","phase":"NA","title":"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC as an Immune System Enhancer Along With Vaccination Against COVID-19","status":"WITHDRAWN","sponsor":"Royal College of Surgeons in Ireland - Medical University of Bahrain","startDate":"2021-08-15","conditions":"SARS-COV 2, Covid19","enrollment":""},{"nctId":"NCT03638622","phase":"PHASE1, PHASE2","title":"Low-cost Enabling Technology for Image-guided Photodynamic Therapy (PDT) of Oral Cancer Cancer.","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-03-10","conditions":"Oral Cancer","enrollment":30},{"nctId":"NCT04636242","phase":"PHASE3","title":"Photodynamic Therapy for Cutibacterium Acnes (C. Acnes) Decolonization of the Shoulder Dermis","status":"UNKNOWN","sponsor":"Rothman Institute Orthopaedics","startDate":"2019-08-22","conditions":"C. Acnes, Phototherapy, Postoperative Infection","enrollment":120},{"nctId":"NCT02157623","phase":"NA","title":"Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome","status":"COMPLETED","sponsor":"Edward Maytin, MD, PhD","startDate":"2016-02-01","conditions":"Basal Cell Nevus Syndrome","enrollment":3},{"nctId":"NCT04020653","phase":"PHASE2","title":"A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria","status":"WITHDRAWN","sponsor":"Neopharma Japan Co., Ltd.","startDate":"2019-09-06","conditions":"Malaria","enrollment":""},{"nctId":"NCT00977795","phase":"PHASE1, PHASE2","title":"A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors","status":"WITHDRAWN","sponsor":"Endeavor Health","startDate":"2009-09","conditions":"Brain Neoplasms","enrollment":""},{"nctId":"NCT02464709","phase":"PHASE4","title":"Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)","status":"COMPLETED","sponsor":"Joint Authority for Päijät-Häme Social and Health Care","startDate":"2015-06","conditions":"Actinic Keratosis, Natural Daylight Photodynamic Therapy","enrollment":72},{"nctId":"NCT03642535","phase":"PHASE4","title":"Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention","status":"UNKNOWN","sponsor":"Shanghai Dermatology Hospital","startDate":"2018-08-30","conditions":"Actinic Keratoses","enrollment":300},{"nctId":"NCT00814528","phase":"NA","title":"Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses","status":"WITHDRAWN","sponsor":"University of Chicago","startDate":"2007-11","conditions":"Actinic Keratosis","enrollment":""},{"nctId":"NCT02239679","phase":"PHASE2","title":"Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy","status":"COMPLETED","sponsor":"DUSA Pharmaceuticals, Inc.","startDate":"2014-09","conditions":"Actinic Keratosis","enrollment":166},{"nctId":"NCT02685592","phase":"PHASE4","title":"Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream","status":"COMPLETED","sponsor":"Joint Authority for Päijät-Häme Social and Health Care","startDate":"2016-02","conditions":"Lentigo Maligna","enrollment":10},{"nctId":"NCT02481141","phase":"NA","title":"Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Type II Diabetes","status":"COMPLETED","sponsor":"SBI Pharmaceuticals Co, Ltd.","startDate":"2014-07","conditions":"Diabetes Mellitus, Type 2","enrollment":53},{"nctId":"NCT03024060","phase":"PHASE3","title":"Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp","status":"WITHDRAWN","sponsor":"DUSA Pharmaceuticals, Inc.","startDate":"2017-03","conditions":"Actinic Keratosis","enrollment":""},{"nctId":"NCT01310868","phase":"PHASE2","title":"Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma","status":"COMPLETED","sponsor":"University College, London","startDate":"2011-05","conditions":"Glioblastoma","enrollment":59},{"nctId":"NCT02355899","phase":"PHASE2","title":"Evaluation of the Suitability of PD P 506 A in the PDT of Distal Subungual Onychomycosis (DSO) of the Great Toenail.","status":"COMPLETED","sponsor":"photonamic GmbH & Co. KG","startDate":"2015-01","conditions":"Onychomycosis","enrollment":25},{"nctId":"NCT02622594","phase":"PHASE4","title":"Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation Times","status":"COMPLETED","sponsor":"Dermatology, Laser & Vein Specialists of the Carolinas","startDate":"2015-10","conditions":"Actinic Keratoses","enrollment":10},{"nctId":"NCT00524485","phase":"NA","title":"Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis","status":"TERMINATED","sponsor":"Roswell Park Cancer Institute","startDate":"2005-05","conditions":"Precancerous/Nonmalignant Condition","enrollment":12},{"nctId":"NCT02799069","phase":"PHASE3","title":"Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2008-04","conditions":"Actinic Keratosis","enrollment":571},{"nctId":"NCT02799082","phase":"PHASE3","title":"Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2007-12","conditions":"Actinic Keratosis","enrollment":122},{"nctId":"NCT01148966","phase":"PHASE1","title":"Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors","status":"TERMINATED","sponsor":"University of Washington","startDate":"2010-06","conditions":"Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma","enrollment":6},{"nctId":"NCT01502605","phase":"PHASE1","title":"Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2012-09","conditions":"Astrocytoma, Glioma","enrollment":6},{"nctId":"NCT00663910","phase":"EARLY_PHASE1","title":"Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2008-03","conditions":"Non-melanomatous Skin Cancer","enrollment":18},{"nctId":"NCT01522677","phase":"PHASE1, PHASE2","title":"A Study of Neoadjuvant Photodynamic Immunomodulation for Colon Cancer","status":"WITHDRAWN","sponsor":"Edward Nelson","startDate":"2012-08","conditions":"Colon Cancer","enrollment":""},{"nctId":"NCT01475955","phase":"PHASE2","title":"Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)","status":"COMPLETED","sponsor":"DUSA Pharmaceuticals, Inc.","startDate":"2011-12","conditions":"Actinic Keratosis","enrollment":235},{"nctId":"NCT02799030","phase":"PHASE2","title":"A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis","status":"COMPLETED","sponsor":"Biofrontera Bioscience GmbH","startDate":"2006-10","conditions":"Actinic Keratosis","enrollment":105},{"nctId":"NCT02755142","phase":"PHASE1, PHASE2","title":"Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas","status":"COMPLETED","sponsor":"medac GmbH","startDate":"2000-02","conditions":"Brain Neoplasm","enrollment":21},{"nctId":"NCT02101931","phase":"PHASE3","title":"A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine","status":"COMPLETED","sponsor":"Princess Al-Johara Al-Ibrahim Cancer Research Center","startDate":"2014-03","conditions":"Transitional Cell Carcinoma of the Bladder","enrollment":100},{"nctId":"NCT02647151","phase":"PHASE4","title":"Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel","status":"UNKNOWN","sponsor":"Fundación Instituto Valenciano de Oncología","startDate":"2015-12","conditions":"Actinic Keratosis","enrollment":50},{"nctId":"NCT02520700","phase":"NA","title":"A Comparison of White-light and Daylight Topical Methyl 5-aminolaevulinic Acid Photodynamic Therapy for Actinic Keratoses","status":"COMPLETED","sponsor":"St Vincent's University Hospital, Ireland","startDate":"2013-09","conditions":"Actinic Keratoses","enrollment":22},{"nctId":"NCT01053000","phase":"NA","title":"Photodynamic Therapy With Levulan® +/- Topical Retinoid Pre-Treatment In The Treatment Of Actinic Keratoses","status":"COMPLETED","sponsor":"Stewart, Roger H., M.D., P.A.","startDate":"2010-01","conditions":"ACTINIC KERATOSES","enrollment":10},{"nctId":"NCT00571974","phase":"PHASE1, PHASE2","title":"Treatment of Oral Premalignant Lesions With 5-ALA PDT","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2007-01","conditions":"Leukoplakia, Erythroplakia","enrollment":29},{"nctId":"NCT00814918","phase":"NA","title":"Topical 5-ALA-PDT With Blu-U Therapy Versus Topical 5-ALA With Pulse Dye Laser In Treating Recalcitrant Acne Vulgaris","status":"WITHDRAWN","sponsor":"University of Chicago","startDate":"2009-02","conditions":"Acne Vulgaris","enrollment":""},{"nctId":"NCT00571558","phase":"PHASE1","title":"Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-03","conditions":"Oral Leukoplakia","enrollment":15},{"nctId":"NCT01491711","phase":"PHASE4","title":"Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate","status":"UNKNOWN","sponsor":"Maastricht University Medical Center","startDate":"2013-08","conditions":"Superficial Basal Cell Carcinoma","enrollment":162},{"nctId":"NCT00054171","phase":"PHASE2","title":"Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"1999-02","conditions":"Leukemia, Lymphoma","enrollment":1},{"nctId":"NCT00865878","phase":"PHASE2","title":"ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients","status":"TERMINATED","sponsor":"DUSA Pharmaceuticals, Inc.","startDate":"2009-05","conditions":"Actinic Keratoses, Skin Neoplasms","enrollment":6},{"nctId":"NCT00671710","phase":"PHASE1","title":"Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain","status":"COMPLETED","sponsor":"Advocate Hospital System","startDate":"2008-04","conditions":"Brain Tumors","enrollment":26},{"nctId":"NCT00988455","phase":"PHASE1, PHASE2","title":"Evaluation of Efficacy of Photodynamic Therapy in Basal Cell Carcinoma With 6 Months Follow-up","status":"COMPLETED","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2008-01","conditions":"Basal Cell Carcinoma","enrollment":28}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"BF-200 ALA 1%","genericName":"BF-200 ALA 1%","companyName":"Biofrontera Bioscience GmbH","companyId":"biofrontera-bioscience-gmbh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Aminolevulinic acid (ALA) 1% is used in photodynamic therapy for conditions such as actinic keratosis. The therapy involves the use of blue light to activate the ALA, which is administered to the affected area.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}